Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy of flexibly dosed paliperidone
extended-release (ER) in participants with schizophrenia (psychiatric disorder with symptoms
of emotional instability, detachment from reality, often with delusions and hallucinations,
and withdrawal into the self) who were previously unsuccessfully treated with other oral
antipsychotics.